Supernus Pharmaceuticals's total assets for Q4 2025 were $1.45B, an increase of 2.32% from the previous quarter. SUPN total liabilities were $390.93M for the fiscal quarter, a 5.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.